Epstein-Barr virus infection after stem cell transplantation: New concepts are needed both for the donor and the recipient

Clinical Infectious Diseases

Volumn 43, Issue 7, 2006, Pages 896-897

  Bitan, Menachem ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CYTOTOXIC T LYMPHOCYTE; EVALUATION; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; NEPHROTOXICITY; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T CELL DEPLETION; VIRUS INFECTION; VIRUS PNEUMONIA; ANIMAL; DONOR; INFECTIOUS MONONUCLEOSIS; RISK FACTOR; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; CYCLOSPORINE; EPSTEIN-BARR VIRUS INFECTIONS; INFECTIOUS MONONUCLEOSIS; RISK FACTORS; STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION;

EID: 33748637335     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/507032     Document Type: Note

References (4)

1. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71:1234-43.
2. Cohen J, Gandhi M, Naik P, et al. Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning. Br J Haematol 2005; 129:229-39.
3. Meijer E, Spijkers S, Moschatsis S, et al. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: reinfection or reactivation? Transpl Infect Dis 2005; 7:4-10.
4. Teira P, Agbalika F, Bergeron A, et al. Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation. Clin Infect Dis 2006; 43:892-5 (in this issue).